Department of Surgery, Medical College of Wisconsin, Milwuakee, Wisonsin.
Division of Interventional Radiology, Department of Radiology, Medical College of Wisconsin, Milwuakee, Wisonsin.
J Surg Res. 2020 Nov;255:124-129. doi: 10.1016/j.jss.2020.04.019. Epub 2020 Jun 16.
There is currently limited data assessing the long-term consequences of thoracic endovascular aortic repair (TEVAR) in otherwise healthy aortic segments remote from the site of endograft coverage. The aim of this study is to retrospectively evaluate aortic remodeling and long-term outcomes of blunt thoracic aortic injury (BTAI) patients treated with TEVAR. Our hypothesis is that significant changes to the aorta proximal to the graft-covered segment are suspected following TEVAR.
An institutional review board-approved retrospective review of patients who underwent TEVAR for BTAI at a level I trauma center from 2004 to 2018 was performed. Forty-six patients were identified and of these, 32 patients with high-resolution computed tomographic angiography imaging follow-up were included in the study. Computed tomographic angiography measurements of aortic dimensions and branch vessels proximal, distal, and adjacent to the stent grafted segment were recorded preprocedure and postprocedure and analyzed. Primary device-related outcomes such as birdbeaking, mural thrombus, stent migration, and persistent endoleak were assessed. Patient outcomes including mortality, graft-related morbidity, and need for secondary interventions were also analyzed.
Mean follow-up of the selected patients in the study was 1.52 y (range, 0.06-8.0 y). Following TEVAR, the ascending aortic length increased significantly (mean 5.7 ± 4.6 mm, P < 0.001). The mean diameters of the ascending aorta (1.5 ± 1.5, P < 0.001 mm), the midaortic arch (1.3 ± 1.7 mm, P < 0.001), and proximal and the distal endograft landing zones (1.9 ± 2.1 mm and 2.2 ± 1.6 mm, respectively, P < 0.001) also increased significantly following TEVAR. Clinically relevant device-related outcomes occurred with the presence of endograft infolding and subsequent development of endograft mural thrombus (P < 0.001). The need for secondary intervention following TEVAR for BTAI was associated with endograft mural thrombus (P < 0.05).
TEVAR for BTAI causes significant geometric changes in the aorta proximal to the stented grafted segment of the aorta. Direct consequences of the graft at the stented segment includes mural thrombus development within the endograft which was associated with the need for secondary intervention. Although clinical significance is yet to be determined, post-TEVAR changes in aortic architecture warrant continued aortic surveillance following BTAI.
目前,关于胸主动脉腔内修复术(TEVAR)治疗远离覆膜支架覆盖部位的健康主动脉节段的长期后果的数据有限。本研究的目的是回顾性评估 TEVAR 治疗钝性胸主动脉损伤(BTAI)患者的主动脉重塑和长期结果。我们的假设是,TEVAR 后怀疑覆膜支架覆盖段近端的主动脉发生显著变化。
对 2004 年至 2018 年在 I 级创伤中心接受 TEVAR 治疗的 BTAI 患者进行机构审查委员会批准的回顾性研究。确定了 46 例患者,其中 32 例具有高分辨率 CT 血管造影成像随访的患者被纳入研究。记录术前和术后支架覆膜段近端、远端和相邻主动脉血管的主动脉尺寸和分支血管的 CT 血管造影测量值,并进行分析。评估了主要与器械相关的结果,如鸟嘴状、壁血栓、支架移位和持续性内漏。还分析了患者的结局,包括死亡率、移植物相关发病率和需要二次干预。
研究中选定患者的平均随访时间为 1.52 年(范围 0.06-8.0 年)。TEVAR 后,升主动脉长度显著增加(平均 5.7 ± 4.6 mm,P < 0.001)。升主动脉(1.5 ± 1.5,P < 0.001 mm)、主动脉弓中段(1.3 ± 1.7 mm,P < 0.001)和近端及远端覆膜支架植入部位(1.9 ± 2.1 和 2.2 ± 1.6 mm,分别,P < 0.001)的平均直径也显著增加。TEVAR 后,支架内折叠和随后支架内壁血栓形成(P < 0.001)导致了与器械相关的临床相关不良事件。TEVAR 治疗 BTAI 后需要二次干预与支架内壁血栓形成(P < 0.05)有关。
TEVAR 治疗 BTAI 导致主动脉覆膜支架植入段近端主动脉的几何形状发生显著变化。支架覆膜段的直接后果包括支架内壁血栓形成,这与需要二次干预有关。虽然其临床意义尚未确定,但 BTAI 后主动脉结构的变化需要继续进行主动脉监测。